Overview

Trandolapril 4 mg Tablet Under Non-Fasting Conditions

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the comparative bioavailability between trandolapril 4 mg tablets (test) and MavikĀ® 4 mg Tablets (reference) after a single-dose in healthy subjects under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Trandolapril